HMGB1 and cancer: Specifically, we integrate four major domains of cancer therapy resistance, genome maintenance and DNA repair, stress-induced autophagy, cell death escape, and multidrug resistance (MDR) programs, and describe how their interplay with HMGB1 positions this protein as a central organizer linking these processes.